# CORMEDIX INC (CRMD)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CRMD/

- Reporting holders: 3
- Reported value: $14.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $6.7K | 875 | 0.0% | 12 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $4.1K | 534 | 0.0% | 7 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $3.8K | 489 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $14.6K |
| Q2 2026 | 199 | $392.4M |
| Q1 2026 | 193 | $304.6M |
| Q4 2025 | 203 | $534.4M |
| Q3 2025 | 192 | $548.1M |
| Q2 2025 | 174 | $444.1M |
| Q1 2025 | 137 | $155.7M |
| Q4 2024 | 130 | $196.7M |
| Q3 2024 | 102 | $166.5M |
| Q2 2024 | 98 | $77.1M |
| Q1 2024 | 89 | $77.5M |
| Q4 2023 | 101 | $73.6M |

